Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer

J Med Chem. 2005 Aug 11;48(16):5373-7. doi: 10.1021/jm050242f.

Abstract

In vivo phosphorylation of FTY720 (1) in rats and humans resulted exclusively in the biologically active (S)-configured enantiomer, which was proven by an ex vivo o-phthaldialdehyde derivatization protocol especially elaborated for phosphates of 1. Starting from the prochiral amino alcohol 1, racemic and enantiomerically pure phosphates of 1 were synthesized. Pure enantiomers were obtained after purification of a partially protected key intermediate on an enantioselective support. The absolute stereochemistry was determined by X-ray diffraction.

MeSH terms

  • Adjuvants, Immunologic / blood*
  • Animals
  • CHO Cells
  • Chromatography, High Pressure Liquid
  • Cricetinae
  • Cricetulus
  • Crystallography, X-Ray
  • Fingolimod Hydrochloride
  • Humans
  • Male
  • Organophosphates / blood*
  • Organophosphates / chemical synthesis
  • Organophosphates / chemistry
  • Organophosphates / pharmacology
  • Phosphorylation
  • Propylene Glycols / blood*
  • Radioligand Assay
  • Rats
  • Rats, Wistar
  • Receptors, Lysosphingolipid / agonists
  • Receptors, Lysosphingolipid / metabolism
  • Sphingosine / analogs & derivatives
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • 2-amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl phosphate
  • Adjuvants, Immunologic
  • Organophosphates
  • Propylene Glycols
  • Receptors, Lysosphingolipid
  • Fingolimod Hydrochloride
  • Sphingosine